Beebe Katherine Insider Trades

Insider Trading History

Track insider trading activity for Beebe Katherine. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Titan Pharmaceuticals (de)
Titan Pharmaceuticals (de) TTNP
President And COO
Holding Value $155k 66,250 shares
Last Trade
Oct 25, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$137k 16,250 shares
$8.44
$2.34
Titan Pharmaceuticals (de)
Titan Pharmaceuticals (de) TTNP
President And COO
Holding Value $117k 50,000 shares
Last Trade
Jul 26, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$522k 50,000 shares
$10.44
$2.34
Titan Pharmaceuticals (de)
Titan Pharmaceuticals (de) TTNP
President And COO
Holding Value $234k 100,000 shares
Last Trade
Jun 29, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.3M 100,000 shares
$13.00
$2.34
Titan Pharmaceuticals (de)
Titan Pharmaceuticals (de) TTNP
President And COO
Holding Value $129k 55,000 shares
Last Trade
Jan 05, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.2M 55,000 shares
$21.80
$2.34
Titan Pharmaceuticals (de)
Titan Pharmaceuticals (de) TTNP
President And COO
Holding Value $351k 150,000 shares
Last Trade
Feb 10, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$12.1M 150,000 shares
$80.40
$2.34
Titan Pharmaceuticals (de)
Titan Pharmaceuticals (de) TTNP
Chief Scientific Officer
Holding Value $5.59k 2,387 shares
Last Trade
Feb 19, 2019 Sale
$54.2M 61,065 shares
$888.00
$2.34

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up